Genetic changes with prognostic value in histologically benign meningiomas

Clinical Neuropathology

Volumn 32, Issue 4, 2013, Pages 311-317

  Barbera, Sandra ^a   Miguel, Teresa San ^a   Gil Benso, Rosario ^a   Muñoz Hidalgo, Lisandra ^a   Roldan, Pedro ^b   Gonzalez Darder, Jose ^b   Cerda Nicolas, Miguel ^a   Lopez Gines, Concha ^a,c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Chromosome 14; Chromosome 1p; Cytogenetics; Meningioma; Recurrence

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAPLASTIC MENINGIOMA; ARTICLE; ATYPICAL MENINGIOMA; BENIGN MENINGIOMA; BENIGN TUMOR; CANCER GRADING; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CHILD; CHROMOSOME 14; CHROMOSOME 1P; CHROMOSOME 22; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MONOSOMY; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR GROWTH; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 84881497794     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300580     Document Type: Article

References (20)

1. Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD. Epidemiology of intracranial meningioma. Cancer. 1993; 72: 639-648.
2. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996; 29: 197-205.
3. Jan M, Bazézé V, Saudeau D, Autret A, Bertrand P, Gouaze A. (Outcome of intracranial meningioma in adults. Retrospective study of a medicosurgical series of 161 meningiomas). Neurochirurgie. 1986; 32: 129-134.
4. Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO classification of tumors of the nervous system. 4th edition. Lyon: IARC; 2007.
5. Mathiesen T, Lindquist C, Kihlström L, Karlsson B. Recurrence of cranial base meningiomas. Neurosurgery. 1996; 39: 2-7.
6. Enam SA, Abdulrauf S, Mehta B, Malik GM, Mahmood A. Metastasis in meningioma. Acta Neurochir (Wien). 1996; 138: 1172-1177.
7. Cerdá-Nicolás M, López-Ginés C, Pérez-Bacete M, Barcia-Salorio JL, Llombart-Bosch A. Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors. Clin Neuropathol. 2000; 19: 259-267.
8. Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet. 2001; 93: 207-220.
9. Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekanne Dit Deprez R, Zwarthoff E. NF2 status of meningiomas is associated with tumour localization and histology. J Pathol. 2001; 194: 367-372.
10. Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK, Golubic M. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. J Neurosurg. 2001; 94: 111-117.
11. Wada K, Maruno M, Suzuki T, Kagawa N, Hashiba T, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T. Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray. Neurol Res. 2005; 27: 747-754.
12. Urbschat S, Rahnenführer J, Henn W, Feiden W, Wemmert S, Linsler S, Zang KD, Oertel J, Ketter R. Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence. Int J Oncol. 2011; 39: 1601-1608.
13. Shaffer LG, Slovak ML, Campbell LJ (eds). ISCN 2009: an international system for human cytogenetic nomenclature. Basel, Switzerland: Karger Publishers; 2009.
14. Ambros PF, Ambros IM; SIOP Europe Neuroblastoma Pathology, Biology, and Bone Marrow Group. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol. 2001; 37: 492-504.
15. Ishino S, Hashimoto N, Fushiki S, Date K, Mori T, Fujimoto M, Nakagawa Y, Ueda S, Abe T, Inazawa J. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer. 1998; 83: 360-366.
16. Sayagués JM, Tabernero MD, Maíllo A, Espinosa A, Rasillo A, Díaz P, Ciudad J, López A, Merino M, Gonçalves JM, Santos-Briz A, Morales F, Orfao A. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? J Mol Diagn. 2004; 6: 316-325.
17. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res. 1995; 55: 4696-4701.
18. Maillo A, Orfao A, Sayagues JM, Diaz P, Gómez-Moreta JA, Caballero M, Santamarta D, Santos-Briz A, Morales F, Tabernero MD. New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology. J Clin Oncol. 2003; 21: 3285-3295.
19. López-Gines C, Cerdá-Nicolas M, Gil-Benso R, Callaghan R, Collado M, Roldan P, Llombart-Bosch A. Association of loss of 1p and alterations of chromosome 14 in meningioma progression. Cancer Genet Cytogenet. 2004; 148: 123-128.
20. Tabernero MD, Espinosa AB, Maillo A, Rebelo O, Vera JF, Sayagues JM, Merino M, Diaz P, Sousa P, Orfao A. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas. Oncologist. 2007; 12: 1225-1236.